Skip to main content
Premium Trial:

Request an Annual Quote

Scienion Raises $5.7M in Financing

NEW YORK, July 18 (GenomeWeb News) - Scienion raised more than €4.5 million ($5.7 million) in its latest round of financing, the company said today.


The company expects to use the funds to establish a second development and production site in Dortmund, Germany, and will move into new facilities in the BioMedizinZentrum Dortmund. Scienion will also develop low-level liquid-handling technologies and applications as part of its expansion strategy.


New investors Nrw.Bank and S-Venture Capital Dortmund joined current investors Peppermint Financial Partners, VC Fonds Berlin of IBB and ERP Start Fonds of Kreditanstalt für Wiederaufbau in this round.


Scienion raised €6 million in its first round of financing in 2001.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.